Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder

Journal of Psychiatry and Neuroscience

Volumn 34, Issue 3, 2009, Pages 175-180

  Konarski, Jakub Z ^a,b   Kennedy, Sidney H ^a,b,c   Segal, Zindel V ^c,d,e   Lau, Mark A ^c,e   Bieling, Peter J ^f   McIntyre, Roger S ^a,c   Mayberg, Helen S ^c,g,h  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b Institute of Medical Science   (Canada)

^c Department of Psychiatry ^*  (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^f MCMASTER UNIVERSITY   (Canada)

^g EMORY UNIVERSITY   (United States)

^h ROTMAN RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; VENLAFAXINE;

ADULT; ARTICLE; BRAIN METABOLISM; CEREBELLUM; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; HYPERMETABOLISM; MAJOR DEPRESSION; MALE; OCCIPITAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PREDICTION; RANDOMIZED CONTROLLED TRIAL; SUBICULUM; TREATMENT FAILURE;

EID: 67749114573     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry 2005;62:409-16.
2. Hollon SD, DeRubeis RJ, Shelton RC, et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry 2005;62:417-22.
3. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longerterm outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163: 1905-17.
4. Hasler G, Drevets WC, Manji HK, et al. Discovering endophenotypes for major depression. Neuropsychopharmacology 2004;29:1765-81.
5. Hollon SD, Jarrett RB, Nierenberg AA, et al. Psychotherapy and medication in the treatment of adult and geriatric depression: Which monotherapy or combined treatment? J Clin Psychiatry 2005; 66:455-68.
6. Joyce PR, Paykel ES. Predictors of drug response in depression. Arch Gen Psychiatry 1989;46:89-99.
7. Amsterdam JD, Fava M, Maislin G, et al. TRH stimulation test as a predictor of acute and long-term antidepressant response in major depression. J Affect Disord 1996;38:165-72.
8. Hollander E, Stein DJ, DeCaria CM, et al. A pilot study of biological predictors of treatment outcome in obsessive-compulsive disorder. Biol Psychiatry 1993;33:747-9.
9. Gallinat J, Bottlender R, Juckel G, et al. The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berl) 2000; 148:404-11.
10. Knott VJ, Telner JI, Lapierre YD, et al. Quantitative EEG in the prediction of antidepressant response to imipramine. J Affect Disord 1996;39:175-84.
11. Eichelbaum M, Ingelman-Sundberg M, Evans WE. Pharmacogenomics and individualized drug therapy. Annu Rev Med 2006;57: 119-37.
12. Malhotra AK, Murphy GM Jr, Kennedy JL. Pharmacogenetics of psychotropic drug response. Am J Psychiatry 2004;161:780-96.
13. Evans KC, Dougherty DD, Pollack MH, et al. Using neuroimaging to predict treatment response in mood and anxiety disorders. Ann Clin Psychiatry 2006;18:33-42.
14. Mayberg HS. Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003;65:193-207.
15. Brody AL, Saxena S, Mandelkern MA, et al. Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biol Psychiatry 2001;50:171-8.
16. Little JT, Ketter TA, Kimbrell TA, et al. Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls. Psychopharmacol Bull 1996;32:629-35.
17. Mayberg HS, Brannan SK, Mahurin RK, et al. Cingulate function in depression: a potential predictor of treatment response. Neuroreport 1997;8:1057-61.
18. Pizzagalli D, Pascual-Marqui RD, Nitschke JB, et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 2001;158:405-15.
19. Pizzagalli D, Oakes T, Fox A, et al. Functional but not structural subgenual prefrontal cortex abnormalities in melancholia. Mol Psychiatry 2004;9:393-405.
20. Wu J, Buchsbaum MS, Gillin JC, et al. Prediction of antidepressant effects of sleep deprivation by metabolic rates in the ventral anterior cingulate and medial prefrontal cortex. Am J Psychiatry 1999; 156:1149-58.
21. Dougherty DD, Weiss AP, Cosgrove GR, et al. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg 2003;99:1010-7.
22. Brody AL, Saxena S, Stoessel P, et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiatry 2001;58:631-40.
23. Martin SD, Martin E, Rai SS, et al. Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings. Arch Gen Psychiatry 2001;58:641-8.
24. Roffman JL, Marci CD, Glick DM, et al. Neuroimaging and the functional neuroanatomy of psychotherapy. Psychol Med 2005;35: 1385-98.
25. Deldin PJ, Chiu P. Cognitive restructuring and EEG in major depression. Biol Psychol 2005;70:141-51.
26. Kennedy SH, Konarski JZ, Segal ZV, et al. Differences in Brain Glucose Metabolism Between Responders to CBT and Venlafaxine in a 16-Week Randomized Controlled Trial. Am J Psychiatry 2007; 164:778-88.
27. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York (NY): Biometrics Research, New York State Psychiatric Institute; 2002.
28. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
29. Frank E, Prien R, Jarrett R, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991;48:851-5.
30. Liotti M, Mayberg H, McGinnis S, et al. Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. Am J Psychiatry 2002; 159:1830-40.
31. Mayberg HS, Liotti MS, Brannan S, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry 1999;156:675-82.
32. Mayberg HS, Brannan SK, Tekell JL, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000;48:830-43.
33. Mayberg HS. Modulating limbic-cortical circuits in depression: targets of antidepressant treatments. Semin Clin Neuropsychiatry 2002;7:255-68.
34. Mayberg HS, Lozano A, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005;45:651-60.
35. Nobler MS, Oquendo MA, Kegeles LS, et al. Decreased regional brain metabolism after ect. Am J Psychiatry 2001;158:305-8.
36. Brody A, Saxena S, Silverman D, et al. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Res 1999;91:127-39.
37. Saxena S, Brody AL, Ho ML, et al. Differential brain metabolic predictors of response to paroxetine in obsessive-compulsive disorder versus major depression. Am J Psychiatry 2003;160:522-32.
38. Papez J. A proposed mechanism of emotion. Arch Neurol Psychiatry 1937;38:725-44.
39. Bush G, Luu P, Posner MI. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci 2000;4:215-22.
40. Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to behaviour. Brain 1995;118:279-306.
41. Vogt BA, Finch DM, Olson CR. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex 1992;2:435-43.
42. Mayberg HS. Limbic-cortical dysregulation: a proposed model of depression. J Neuropsychiatry Clin Neurosci 1997;9:471-81.
43. Siegle GJ, Carter CS, Thase ME. Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am J Psychiatry 2006;163:735-8.
44. Seminowicz DA, Mayberg HS, McIntosh AR, et al. Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage 2004;22:409-18.
45. Goldapple K, Segal Z, Garson C, et al. Modulation of corticallimbic pathways in major depression: treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 2004;61:34-41.